EP2209491
MOLECULES AND METHODS FOR MODULATING LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (LRP6)
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.10.2008EP published:
28.10.2015EP application number:
08844924.4
EPO information:
European Patent Register
Max expiry date:
30.10.2028
Title:
MOLECULES AND METHODS FOR MODULATING LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (LRP6)
Timeline
Today
31.10.2008EP application
28.10.2015EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
CONG, FengAddress:
Quincy, Massachusetts, US
Name:
RANGWALA, Shamina M.Address:
Brookline, Massachusetts, US
Name:
ETTENBERG, SethAddress:
Melrose, Massachusetts, US
Name:
GUTH, SabineAddress:
Basel, CH
Priority
Number:
984827 PDate:
2.11.2007Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 35/00